Alivecor has suffered from another Nixan in the long -term patent case against Apple. Today, the American Court of Appeal for the Federal Department Declaration of a decision The patents of the EKG medical hardware maker are not actually innocent. As a result, Apple Watch will not face a second ban on import from the International Trade Committee (ITC).
This started back and forth between Alivecor and Apple in 2021. Alivecor went to ITC, claiming that Apple had violated EKG patents. ITC ruled in favor of Alivecor, and recommends an import ban that would prevent the sale of Apple watches with the EKG feature in the United States. However, this did not immediately come into effect because the invention and appeal patent trial also destroyed that the three patent patents concerned were not valid. For an advanced ban, alivecor had to win it attractiveness From PTAB Resolution – which he did not.
“We are deeply disappointed by the court’s decisions this morning and that the court did not review the available secondary considerations, which ITC found convincing to find it from the authority,” says Sanjay Volti, Senior Business Office at Alivecor. “We will continue to explore all available legal options, including possible appeals, to defend our position that our patents are valid and that Apple has violated our intellectual property rights.”
We thank the federal circle for carefully looking at it in this case. Apple teams have worked tirelessly over many years to develop health, wellness and safety features in the industry that beneficially affects the lives of users, and we intend to stay on this path. ” freedom.
Alivecor uses the same legal strategy as Masimo, other medical hardware maker. but, Massimo He was successful Try to get an ITC import ban against Apple Watch. The main difference is that MASIMO Patents were above Apple Watch, not EKG technology. To overcome the ITC, Apple import ban now The blood oxygen sensor is disrupted In the newly sold Apple watches in the United States.
